Inactive Instrument
InterCure Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
INCR
IL0011063760
Healthcare Facilities & Services
| Market Cap | 161M 490M 141M 131M 121M 226M 15.49B 230M 1.56B 609M 7.61B 604M 591M 26.33B | P/E 2024 |
-4.01x | P/E 2025 | -4.87x |
|---|---|---|---|---|---|
| Enterprise Value | 297M 905M 261M 243M 223M 418M 28.62B 425M 2.88B 1.13B 14.07B 1.12B 1.09B 48.64B | EV / Sales 2024 |
1.69x | EV / Sales 2025 | 1.16x |
| Free-Float |
60.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2019-12-23 | |
Amos Cohen
DFI | Director of Finance/CFO | 47 | 2020-02-29 |
Itai Kabiljo
LAW | General Counsel | - | 2022-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 2015-09-02 | |
David Salton
BRD | Director/Board Member | 66 | 2014-12-13 |
| Chairman | 55 | 2025-02-12 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -0.51% | - | - | 51.28M | |
| -1.03% | -2.03% | +36.88% | +201.66% | 223M | |
| +2.15% | -1.04% | +5.56% | +106.52% | 130M | |
| +3.12% | +5.60% | -36.54% | -25.84% | 128M | |
| -6.02% | -7.14% | -2.50% | -40.00% | 84.23M | |
| -0.25% | -7.81% | -14.82% | -10.85% | 80.1M | |
| Average | -0.30% | -2.63% | -2.28% | +46.30% | 129.09M | |
| Weighted average by Cap. | -0.09% | -2.03% | +4.45% | +79.46% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 239M 727M 210M 195M 179M 336M 23B 342M 2.32B 905M 11.31B 897M 877M 39.1B | 270M 823M 237M 221M 203M 381M 26.02B 386M 2.62B 1.02B 12.79B 1.01B 992M 44.23B |
| Net income | -67.8M -206M -59.54M -55.37M -50.81M -95.48M -6.53B -96.95M -658M -257M -3.21B -255M -249M -11.1B | -35.71M -109M -31.36M -29.17M -26.77M -50.29M -3.44B -51.07M -346M -135M -1.69B -134M -131M -5.85B |
| Net Debt | 133M 404M 117M 108M 99.5M 187M 12.78B 190M 1.29B 503M 6.29B 498M 488M 21.73B | 136M 415M 120M 111M 102M 192M 13.13B 195M 1.32B 517M 6.45B 512M 501M 22.32B |
Employees
-
